BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 318672)

  • 1. Clinical study of a patient with lupus vulgaris before and after injection of dialyzable transfer factor.
    Horsmanheimo M; Krohn K; Virolainen M
    J Invest Dermatol; 1977 Jan; 68(1):10-5. PubMed ID: 318672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor.
    Horsmanheimo M; Krohn K; Virolainen M; Blomqvist K
    Arch Dermatol; 1979 Feb; 115(2):180-4. PubMed ID: 426525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of transfer factor in patients with depressed cellular immunity and chronic infection.
    Rocklin RE
    Birth Defects Orig Artic Ser; 1975; 11(1):431-5. PubMed ID: 1096987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of tuberculin sensitivity after injection of dialyzable transfer factor in sarcoidosis.
    Horsmanheimo M; Virolainen M
    Ann N Y Acad Sci; 1976; 278():129-35. PubMed ID: 1067003
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blastic lymphocyte transformation induced with phytohemagglutinin and tuberculin in skin tuberculosis].
    Pluzańska A; Arkuszewska C
    Przegl Dermatol; 1978; 65(6):661-5. PubMed ID: 725106
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical mycobacterium infection treated with dialyzable leukocyte extracts: evidence for antigenic specificity.
    Simon MR; Salberg DJ; Silva J; Ganji S; Desai S; Muller BF; Palutke M
    Clin Immunol Immunopathol; 1981 Jul; 20(1):123-8. PubMed ID: 6167387
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immunity in acne vulgaris during transfer factor treatment.
    Ashorn R; Uotila A; Kuokkanen K; Räsänen L; Karhumäki E; Krohn K
    Ann Clin Res; 1985; 17(4):152-5. PubMed ID: 2934019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer factor treatment in a patient with progressive tuberculosis.
    Rubinstein A; Melamed J; Rodescu D; Murphy RA; Broocker D
    Clin Immunol Immunopathol; 1977 Jul; 8(1):39-50. PubMed ID: 301805
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. 1. Antigen-dependent inhibition and antigen-independent inhibition and enhancement of migration.
    Wilson GB; Fudenberg HH; Horsmanheimo M
    J Lab Clin Med; 1979 May; 93(5):800-18. PubMed ID: 429876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial transfer of delayed hypersensitivity with dialyzable transfer factor.
    Kirkpatrick CH; Smith TK
    Cell Immunol; 1976 Dec; 27(2):323-7. PubMed ID: 795550
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuberculin anergy in clinically normal individuals. I. Lymphokine and lymphocyte transformation studies.
    Muller HK; Pye DW; Martin CL; Kimpton WG
    Int Arch Allergy Appl Immunol; 1983; 70(1):65-70. PubMed ID: 6336724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity: correlation of mixed-leucocyte-macrophage migration inhibition with delayed-type hypersensitivity after immunization and donor-specific transfer of cell migration inhibition by dialyzable leucocyte extract.
    Mazaheri R; Hamblin AS; Zuckerman AJ
    Cell Immunol; 1983 Nov; 82(1):147-62. PubMed ID: 6196129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfer factor therapy for histoplasmosis in a patient with Hodgkin's disease.
    Catanzaro A; Spitler LE; Campbell GD; Moser KM
    Arch Intern Med; 1981 Mar; 141(4):533-7. PubMed ID: 7212899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human dialyzable transfer factor from normal and chronic lymphoid leukemia sources.
    Goust JM; Marescot MR; Lesourd B; Doumercq S; Moulias R
    Biomedicine; 1976 Jan; 24(1):39-44. PubMed ID: 817750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer factor: delayed hypersensitivity to Schistosoma mansoni and tuberculin in Macaca mulatta.
    Maddison SE; Hicklin MD; Conway BP; Kagan IG
    Science; 1972 Nov; 178(4062):757-9. PubMed ID: 4628344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer factor therapy in ataxia--telangiectasia.
    Berkel AI; Ersoy F; Epstein LB; Spitler LE
    Clin Exp Immunol; 1977 Sep; 29(3):376-84. PubMed ID: 201409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus vulgaris with squamous cell carcinoma.
    Motswaledi MH; Doman C
    J Cutan Pathol; 2007 Dec; 34(12):939-41. PubMed ID: 18001418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity and transfer factor in Crohn's disease.
    Ng RP; Vicary FR
    Br Med J; 1976 Jul; 2(6027):87-8. PubMed ID: 1084205
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of delayed hypersensitivity in patients with cutaneous tuberculosis by the in vivo and in vitro methods].
    Arkuszewska C; Olszewska Z; Płuzańska A
    Przegl Dermatol; 1980; 67(1):31-6. PubMed ID: 7375651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.